Effects of Oral Tofacitinib on Patient-Reported Outcomes in Patients With Moderate to Severe Crohn's Disease: Results of Two Phase 2B Randomized Placebo-Controlled Trials

被引：0
|
作者：
Panes, Julian
Chan, Gary
Maller, Eric
Moscariello, Michele
Wang, Wenjin
Healey, Paul J.
机构：
来源：
GASTROENTEROLOGY | 2016年 / 150卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu2004
引用
收藏
页码：S1003 / S1003
页数：1
相关论文
共 50 条
  • [31] Effects of upadacitinib on atopic dermatitis signs, symptoms and patient-reported outcomes from a phase IIb randomized, placebo-controlled trial
    De Bruin-Weller, M. S.
    Guttman-Yassky, E.
    Forman, S. B.
    Bodhani, A.
    Chen, S.
    Pangan, A. L.
    Teixeira, H. D.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (01) : E13 - E13
  • [32] Patient-reported outcomes in subjects receiving botulinum toxin type A (BoNTA) treatment for moderate to severe glabellar rhytids: Results from two randomized, double-blind, placebo-controlled studies
    Fagien, Steven
    Stone, Catherine
    Cox, Sue Ellen
    Werschler, William Philip
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (02) : AB197 - AB197
  • [33] Efficacy and Safety of Epratuzumab in Patients with Moderate-to-Severe Systemic Lupus Erythematosus: Results from Two Phase 3 Randomized, Placebo-Controlled Trials
    Clowse, Megan E. B.
    Wallace, Daniel J.
    Furie, Richard
    Petri, Michelle
    Pike, Marilyn
    Leszczynski, Piotr
    Neuwelt, C. Michael
    Hobbs, Kathryn
    Keiserman, Mauro
    Duca, Liliana
    Kalunian, Kenneth
    Bongardt, Sabine
    Stach, Christian
    Beaudot, Carolyn
    Kilgallen, Brian
    Galateanu, Catrinel
    Gordon, Caroline
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [34] Risankizumab significantly improves patient-reported outcomes in moderate to severe psoriasis in two phase III UltIMMa trials
    Augustin, M.
    Lambert, J.
    Zema, C.
    Thompson, E. H.
    Yang, M.
    Wu, E.
    Geng, Z.
    Valdes, J.
    Skup, M.
    Gordon, K.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 118 - 118
  • [35] Onercept for moderate-to-severe Crohn's disease: A randomized, double-blind, placebo-controlled trial
    Rutgeerts, Paul
    Sandborn, William J.
    Fedorak, Richard N.
    Rachmilewitz, Daniel
    Tarabar, Dino
    Gibson, Peter
    Nielsen, Ole Haagen
    Wild, Gary
    Schreiber, Stefan
    Rossi, Claudia Pena
    Zignani, Monia
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2006, 4 (07) : 888 - 893
  • [36] Upadacitinib improved patient-reported sleep in moderate-to-severe atopic dermatitis: results from a phase zb randomized, placebo controlled trial
    Reich, K.
    Liu, M.
    Calimlim, B.
    Teixeira, H. D.
    Silverberg, J. I.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 : 60 - 61
  • [37] Induction Therapy with Certolizumab Pegol in Patients with Moderate to Severe Crohn's Disease: A Placebo-Controlled Trial
    Sandborn, William
    Schreiber, Stefan
    Feagan, Brian
    Rutgeerts, Paul
    Younes, Ziad
    Bloomfield, Ralph
    Guzman, Juan Pablo
    D'Haens, Geert
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S419 - S419
  • [38] Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD)
    Simpson, Eric L.
    Gadkari, Abhijit
    Worm, Margitta
    Soong, Weily
    Blauvelt, Andrew
    Eckert, Laurent
    Wu, Richard
    Ardeleanu, Marius
    Graham, Neil M. H.
    Pirozzi, Gianluca
    Sutherland, E. Rand
    Mastey, Vera
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 75 (03) : 506 - 515
  • [39] Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 Trials
    Armstrong, April W.
    Augustin, Matthias
    Beaumont, Jennifer L.
    Pham, Tan P.
    Hudgens, Stacie
    Gordon, Kenneth B.
    Zhuo, Joe
    Becker, Brandon
    Zhong, Yichen
    Kisa, Renata M.
    Banerjee, Subhashis
    Papp, Kim A.
    [J]. DERMATOLOGY AND THERAPY, 2024, 14 (08) : 2235 - 2248
  • [40] Patient-Reported Outcomes From the Randomized Phase 2b/3 PRISM Trial Evaluating Oral Nalbuphine Extended-Release Versus Placebo in Patients With Prurigo Nodularis
    Staender, Sonja
    Weisshaar, Elke
    Parish, Jennifer L.
    Szepietowski, Jacek C.
    Reich, Adam
    Korman, Neil J.
    Bortey, Enoch
    Sciascia, Thomas R.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB73 - AB73
12345